Myeloma Articles

30th January 2009

NICE have changed guidance that rejected NHS use of a bone marrow cancer drug.

28th October 2008

Patient groups call for a pharmaceutical firm to cut the cost of a bone marrow cancer drug.

27th August 2008

Doctors keep cancer patients in the dark about expensive new drugs that could extend their lives.

25th October 2007

NICE publish final guidance on the use of bortezomib (Velcade) for treatment of multiple myeloma.